Pfizer (PFE) Goodwill (2009 - 2026)

Pfizer (PFE) has reported Goodwill for 18 consecutive years, with $71.4 billion the latest figure, recorded in Q2 2026.

• On a quarterly basis, Goodwill rose 3.51% year-over-year to $71.4 billion in Q2 2026; TTM through Jun 2026 was $71.4 billion, a 3.51% increase from a year earlier, with the FY2025 full-year figure at $71.3 billion, up 3.99% from the prior year.
• Goodwill was $71.4 billion for Q2 2026 at Pfizer, roughly flat from $71.4 billion in the prior quarter.
• Over five years, Goodwill peaked at $71.4 billion in Q2 2026 and troughed at $49.9 billion in Q3 2022.
• A 5-year average of $63.6 billion and a median of $68.5 billion in 2024 frame the typical range for Goodwill.
• Across the five-year window, Goodwill soared 34.62% in 2024 and slipped 1.23% in 2025, its largest moves.
• Over 5 years, Goodwill stood at $51.4 billion in 2022, then jumped by 31.94% to $67.8 billion in 2023, then advanced by 1.1% to $68.5 billion in 2024, then grew by 3.99% to $71.3 billion in 2025, then gained by 0.22% to $71.4 billion in 2026.
• The last three Goodwill figures came in at $71.4 billion (Q2 2026), $71.4 billion (Q1 2026), and $71.3 billion (Q4 2025), per Business Quant data.